Family support can motivate people with diabetes mellitus to improve self-management behaviors and ultimately their glycemic control.
In the current issue of Family Medicine and Community Health (Volume 6, Number 4, 2018; DOI: https://doi.org/10.15212/FMCH.2018.0115, Nnenna A. Osuji, Oluwaseun Solomon Ojo, Sunday O. Malomo, Peter T. Sogunle, Ademola O. Egunjobi and Olufisayo O. Odebunmi of the Family Medicine Department, Federal Medical Centre, Abeokuta, Nigeria describe how Nigeria and other sub-Saharan African countries are currently experiencing a rapid increase in the incidence of noncommunicable diseases, especially diabetes mellitus (DM), as a result of increasing urbanization and changing lifestyles.
Type 2 Diabetes
Globalization and changing lifestyles has made diabetes very common in developing countries so much so that India is known as the Diabetes Capital of the World.
Advertisement
‘People with diseases such as Diabetes Mellitus (DM) that require lifelong management may be tired of taking medications and adhering to the lifestyle modifications over time. ’
Tweet it Now
This underscores the importance of motivation in people with DM. Few studies have looked at the relationship between perceived family support and glycemic control among people with type 2 DM.
Source: Eurekalert
Diabetes - Oral Hypoglycemic Agents and Glycemic Control
Glycemic control in type 2 diabetes is achieved with oral diabetic medications. Combination drugs and insulin therapy is sometimes required.
Advertisement
 Glycemic Index CalculatorLow GI food helps in managing diabetes and body weight. Check out our GI calculator to chalk out the most appropriate diet plan. | Advertisement
|
15 Unknown Facts About Diabetes
Diabetes is the leading cause of death in the world. Here are some interesting facts about diabetes
Advertisement
Recommended Readings
Latest Diabetes News
Physical activity or exercise in the morning and afternoon reduces type 2 diabetes risk, whereas evening exercise has no such association.
Late sleepers and late risers may both have a higher risk of developing diabetes.
Semaglutide, the anti-diabetic drug operating by stimulating insulin secretion, might have the potential to supplant the need for mealtime insulin injections.
The gut bacteria known as Lachnospiraceae might have the ability to boost insulin sensitivity, potentially providing a protective barrier against diabetes.
Type 2 diabetes-led cardiovascular risk needs mandatory interdisciplinary, patient-centered care to reduce morbidity and mortality.
